Skip to content
value.today

Tectonic Therapeutic, Inc.

TECX
$66 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
For year ending December-2025
Net income
$-74 M
SEC filing
Employees
60
As of December 31, 2025
value.today research

Tectonic Therapeutic, Inc. in brief

Tectonic Therapeutic, Inc. is a listed company in the Biotechnology industry, based in Massachusetts, USA. It was founded in 2015. Its last known market value was $66 M (January 2024); there is no current figure. It employs about 60 people and Alise Reicin is its chief executive. Its shares trade under the symbol TECX (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Tectonic Therapeutic, Inc.

Avrobio is a Clinical Stage Personalized Gene Therapy company. It is having 85 employees as on 2019. The headquarters is in USA.

Tectonic Therapeutic, Inc. timeline

5 events, 2015–2024
  1. 2015
  2. 🏁
    · approximate
    Founded
  3. 2016
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2018
  6. 🔔
    · approximate
    Initial public offering on Nasdaq
  7. 🔔
    Initial public offering as AVROBIO, Inc.
    Final prospectus filed with the SEC on 21 June 2018; shares registered for exchange trading on 18 June 2018.
  8. 2024
  9. ✎
    Renamed Tectonic Therapeutic, Inc.
    Formerly AVROBIO, Inc..

Events of Tectonic Therapeutic, Inc. from the company record and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$171 M$342 M$513 M$684 M20202021202220232024

World rank over time

▼ down 13,711 places since 2020
2020-01-01: #9781#9,78120202021-01-01: #10474#10,47420212022-01-07: #23218#23,21820222022-12-25: #27121#27,12120222023-07-30: #23709#23,70920232024-01-05: #23492#23,4922024

Rank in USA: #2,286 (Jan 2020) · #2,631 (Jan 2021) · #4,469 (Jan 2022) · #5,042 (Dec 2022) · #4,524 (Jul 2023) · #3,928 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
—
Operating margin
—
Return on equity
-29.5%
Liabilities / assets
3.7%
Net debt
$-78M
Profit per employee
$-1.2 M

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue —, net income $-46M—FY18Fiscal year ending Dec 2019: revenue —, net income $-73M—FY19Fiscal year ending Dec 2020: revenue —, net income $-120M—FY20Fiscal year ending Dec 2021: revenue —, net income $-119M—FY21Fiscal year ending Dec 2022: revenue —, net income $-106M—FY22Fiscal year ending Dec 2023: revenue —, net income $-43M—FY23Fiscal year ending Dec 2024: revenue —, net income $-58M—FY24Fiscal year ending Dec 2025: revenue —, net income $-74M—FY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025——$-84M$-74M—
Dec 2024——$-58M$-58M—
Dec 2023——$-45M$-43M—
Dec 2022——$-105M$-106M—
Dec 2021——$-119M$-119M—
Dec 2020——$-120M$-120M—
Dec 2019——$-76M$-73M—
Dec 2018——$-46M$-46M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-60M$0M$-60M$-4.05$0.00
Dec 2024$-59M$0M$-59M$-6.83$0.00
Dec 2023$-41M$0M$-41M$-33.76—
Dec 2022$-97M$0M$-97M$-2.42—
Dec 2021$-98M$2M$-100M$-2.78—
Dec 2020$-99M$1M$-100M$-3.31—
Dec 2019$-68M$2M$-69M$-2.66—
Dec 2018$-38M$2M$-39M$-3.62—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue —, net income $-12M—Dec ’24Three months to Mar 2025: revenue —, net income $-16M—Mar ’25Three months to Jun 2025: revenue —, net income $-20M—Jun ’25Three months to Sep 2025: revenue —, net income $-19M—Sep ’25Three months to Dec 2025 (from the annual report): revenue —, net income $-19M—Dec ’25Three months to Mar 2026: revenue —, net income $-25M—Mar ’26Three months to Jun 2026: revenue —, net income $-22M—Jun ’26Three months to Sep 2026: revenue —, net income $-21M—Sep ’26

Latest quarter to Sep 2026: revenue —, net income $-21M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Tectonic Therapeutic, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
—
Operating income
$-84 M
Net income
$-74 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$261 M
Total liabilities
$10 M
Total equity
$251 M

As of December-2025

Top 100 institutional investors in Tectonic Therapeutic, Inc.#

As of Sep 30, 2026
116 institutions held 14.3 M shares (about 71.6% of the shares outstanding) on Sep 30, 2026. The ten largest hold 42.7%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Tectonic Therapeutic, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1FMR LLC2,932,368+101,990 (+3.60%)14.70%$68 MNov 10, 2026
2TCG Crossover Management, LLC1,204,8910 (0.00%)6.04%$28 MNov 16, 2026
3BlackRock, Inc.860,736-1,856 (-0.22%)4.31%$20 MNov 13, 2026
4Baker Bros. Advisors LP607,7880 (0.00%)3.05%$14 MNov 16, 2026
55AM Venture Management, LLC606,6600 (0.00%)3.04%$14 MNov 16, 2026
6Vanguard Capital Management LLC512,412+23,607 (+4.83%)2.57%$12 MNov 13, 2026
7First Light Asset Management, LLC495,950-304,776 (-38.06%)2.49%$12 MNov 16, 2026
8Aberdeen Group plc484,887-656,937 (-57.53%)2.43%$11 MNov 10, 2026
9Marshall Wace, LLP446,511+274,410 (+159.45%)2.24%$10 MNov 13, 2026
10Braidwell LP371,102-225,798 (-37.83%)1.86%$9 MNov 16, 2026
11Vestal Point Capital, LP360,000-65,000 (-15.29%)1.80%$8 MNov 16, 2026
12Ikarian Capital, LLC306,338+100,501 (+48.83%)1.54%$7 MNov 16, 2026
13Kennedy Capital Management LLC302,542+20,340 (+7.21%)1.52%$7 MNov 13, 2026
14Geode Capital Management, LLC283,119+12,658 (+4.68%)1.42%$7 MNov 6, 2026
15State Street Corp220,780+872 (+0.40%)1.11%$5 MNov 12, 2026
16Raymond James Financial Inc197,393+124,719 (+171.61%)0.99%$5 MNov 12, 2026
17Citadel Advisors LLC193,039+102,646 (+113.56%)0.97%$4 MNov 16, 2026
18Sphera Funds Management LTD.187,438New0.94%$4 MNov 16, 2026
19Goldman Sachs Group Inc184,429+110,505 (+149.48%)0.92%$4 MNov 16, 2026
20D. E. Shaw & Co., Inc.182,528-4,022 (-2.16%)0.92%$4 MNov 16, 2026
21Qube Research & Technologies Ltd178,427New0.89%$4 MNov 13, 2026
22ExodusPoint Capital Management, LP167,083+131,844 (+374.14%)0.84%$4 MNov 16, 2026
23Orbimed Advisors LLC166,102-60,498 (-26.70%)0.83%$4 MNov 16, 2026
24Ameriprise Financial Inc143,027+579 (+0.41%)0.72%$3 MNov 16, 2026
25Squarepoint Ops LLC141,065-3,963 (-2.73%)0.71%$3 MNov 9, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Tectonic Therapeutic, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Bollard Group LLC140,953-162,000 (-53.47%)0.71%$3 MNov 13, 2026
27Vanguard Portfolio Management LLC138,738+44,324 (+46.95%)0.70%$3 MNov 13, 2026
28HRT Financial LP134,756+90,216 (+202.55%)0.68%$3 MNov 13, 2026
29Millennium Management LLC126,963-38,562 (-23.30%)0.64%$3 MNov 16, 2026
30Hudson Bay Capital Management LP125,000New0.63%$3 MNov 13, 2026
31Wells Fargo & Company/mn115,508-1,920 (-1.64%)0.58%$3 MNov 16, 2026
32Northern Trust Corp115,119+1,215 (+1.07%)0.58%$3 MNov 16, 2026
33Woodline Partners LP100,0000 (0.00%)0.50%$2 MNov 16, 2026
34Balyasny Asset Management L.P.91,096New0.46%$2 MNov 16, 2026
35Boothbay Fund Management, LLC90,278+29,507 (+48.55%)0.45%$2 MNov 16, 2026
36Vanguard Fiduciary Trust Co79,900+11,506 (+16.82%)0.40%$2 MNov 13, 2026
37Morgan Stanley75,142+9,769 (+14.94%)0.38%$2 MNov 13, 2026
38Sectoral Asset Management Inc72,592+1,583 (+2.23%)0.36%$2 MNov 13, 2026
39Jane Street Group, LLC67,247+1,426 (+2.17%)0.34%$2 MNov 12, 2026
40Connor, Clark & Lunn Investment Management Ltd.64,687-253 (-0.39%)0.32%$2 MNov 10, 2026
41Jump Financial, LLC60,534+17,134 (+39.48%)0.30%$1 MNov 13, 2026
42Trexquant Investment LP57,870+20,879 (+56.44%)0.29%$1 MNov 16, 2026
43Jpmorgan Chase & Co53,760-1,604 (-2.90%)0.27%$1 MNov 12, 2026
44Dimensional Fund Advisors LP53,705+43,262 (+414.27%)0.27%$1 MNov 4, 2026
45ADAR1 Capital Management, LLC49,501+35,000 (+241.36%)0.25%$1 MNov 16, 2026
46Price T Rowe Associates Inc /MD/48,0010 (0.00%)0.24%$1 MNov 16, 2026
47Susquehanna International Group, LLP43,617New0.22%$1 MNov 16, 2026
48XTX Topco Ltd41,963New0.21%$1 MNov 16, 2026
49Y-Intercept (Hong Kong) Ltd41,463New0.21%$1 MOct 16, 2026
50Wellington Management Group LLP37,149+5,717 (+18.19%)0.19%$1 MNov 16, 2026
51Aldebaran Capital, LLC36,220-577 (-1.57%)0.18%$1 MNov 13, 2026
52Charles Schwab Investment Management Inc31,765+1,327 (+4.36%)0.16%$1 MNov 16, 2026
53Monimus Capital Management, LP28,1430 (0.00%)0.14%$1 MNov 16, 2026
54Simplex Trading, LLC27,520+27,081 (+6168.79%)0.14%$1 MNov 4, 2026
55Tetragon Partners GP Ltd26,798-19,718 (-42.39%)0.13%$1 MNov 16, 2026
56Alps Advisors Inc25,886+6,739 (+35.20%)0.13%$1 MNov 3, 2026
57Bank of New York Mellon Corp25,636+389 (+1.54%)0.13%$1 MNov 5, 2026
58American Century Companies Inc23,143+4,142 (+21.80%)0.12%$1 MNov 12, 2026
59Russell Investments Group, Ltd.21,978+16,411 (+294.79%)0.11%$1 MNov 6, 2026
60Engineers Gate Manager LP19,336New0.10%$0 MNov 16, 2026
61Fisher Asset Management, LLC19,1220 (0.00%)0.10%$0 MNov 6, 2026
62SEI Investments Co17,0290 (0.00%)0.09%$0 MNov 10, 2026
63Clearstead Advisors, LLC16,6300 (0.00%)0.08%$0 MNov 6, 2026
64UBS Group AG15,786+731 (+4.86%)0.08%$0 MNov 10, 2026
65Nuveen, LLC14,960+1,446 (+10.70%)0.07%$0 MNov 10, 2026
66Barclays PLC14,731+5,603 (+61.38%)0.07%$0 MNov 6, 2026
67Quantinno Capital Management LP13,705New0.07%$0 MNov 13, 2026
68Rhumbline Advisers13,199-574 (-4.17%)0.07%$0 MNov 10, 2026
69Bank Of America Corp /de/12,452+1,409 (+12.76%)0.06%$0 MNov 16, 2026
70Strs Ohio12,200New0.06%$0 MOct 30, 2026
71Seven Fleet Capital Management LP12,000New0.06%$0 MNov 16, 2026
72Gsa Capital Partners LLP11,304+3,029 (+36.60%)0.06%$0 MNov 16, 2026
73China Universal Asset Management Co., Ltd.10,767+5,264 (+95.66%)0.05%$0 MOct 28, 2026
74Virtus Investment Advisers, LLC10,480-326 (-3.02%)0.05%$0 MNov 12, 2026
75Deutsche Bank AG\8,732-1,307 (-13.02%)0.04%$0 MNov 6, 2026
76AlphaCentric Advisors LLC7,161+213 (+3.07%)0.04%$0 MNov 3, 2026
77MetLife Investment Management, LLC6,7240 (0.00%)0.03%$0 MNov 16, 2026
78Nisa Investment Advisors, LLC5,4000 (0.00%)0.03%$0 MOct 20, 2026
79Vanguard Global Advisers, LLC5,051-3,714 (-42.37%)0.03%$0 MNov 13, 2026
80MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.4,962+268 (+5.71%)0.02%$0 MNov 16, 2026
81New York State Common Retirement Fund4,6000 (0.00%)0.02%$0 MNov 17, 2026
82Los Angeles Capital Management LLC3,600New0.02%$0 MNov 12, 2026
83BNP Paribas Financial Markets3,005-2,141 (-41.61%)0.02%$0 MNov 12, 2026
84Citigroup Inc2,846-2,702 (-48.70%)0.01%$0 MNov 4, 2026
85UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2,841+2,459 (+643.72%)0.01%$0 MNov 16, 2026
86Police & Firemen's Retirement System of New Jersey2,6380 (0.00%)0.01%$0 MNov 9, 2026
87Royal Bank Of Canada1,510+1,199 (+385.53%)0.01%$0 MNov 16, 2026
88Ameritas Investment Partners, Inc.1,1220 (0.00%)0.01%$0 MNov 13, 2026
89US Bancorp \de\1,070-10 (-0.93%)0.01%$0 MNov 5, 2026
90Legal & General Group Plc1,0000 (0.00%)0.01%$0 MNov 16, 2026
91Mirae Asset Global Investments Co., Ltd.999+155 (+18.36%)0.01%$0 MOct 29, 2026
92Chung Wu Investment Group, LLC8000 (0.00%)0.00%$0 MNov 3, 2026
93HighMark Wealth Management LLC5870 (0.00%)0.00%$0 MNov 17, 2026
94GF Fund Management Co. LTD.433+33 (+8.25%)0.00%$0 MOct 26, 2026
95Tower Research Capital LLC (TRC)418-243 (-36.76%)0.00%$0 MNov 16, 2026
96State of Wyoming399-202 (-33.61%)0.00%$0 MOct 28, 2026
97Rockefeller Capital Management L.P.3700 (0.00%)0.00%$0 MNov 13, 2026
98GAMMA Investing LLC314+24 (+8.28%)0.00%$0 MOct 8, 2026
99Federation des caisses Desjardins du Quebec2500 (0.00%)0.00%$0 MNov 16, 2026
100Sterling Capital Management LLC237+61 (+34.66%)0.00%$0 MOct 22, 2026

All 116 institutional investors, with who bought and sold →

Mutual funds holding Tectonic Therapeutic, Inc.#

114 funds hold shares worth $148 M (about 22.8% of the company). Since their previous reports 47 added shares and 25 sold, selling $1 M net.
Mutual funds holding Tectonic Therapeutic, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 abrdn Healthcare Investorsabrdn Inc.770,940$27 M3.9%1.9%no changeJun 30, 2026
🇺🇸 Fidelity Growth Company FundFidelity Management & Research Company LLC720,235$22 M3.6%0.02%+2.9%May 31, 2026
🇺🇸 abrdn Life Sciences Investorsabrdn Inc.370,884$13 M1.9%1.8%no changeJun 30, 2026
🇺🇸 Select Biotechnology PortfolioFidelity Management & Research Company LLC405,389$13 M2.0%0.24%−8.5%May 31, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.364,413$13 M1.8%<0.01%+4.3%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors268,951$9 M1.3%0.01%−0.5%Jun 30, 2026
🇺🇸 Fidelity Growth Company K6 FundFidelity Management & Research Company LLC248,743$8 M1.2%0.03%+1.2%May 31, 2026
🇺🇸 Fidelity Series Growth Company FundFidelity Management & Research Company LLC196,522$6 M0.99%0.03%+2.9%May 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.111,919$4 M0.56%<0.01%+0.3%Jun 30, 2026
🇺🇸 Columbia Small Cap Growth FundColumbia Funds Series Trust I121,484$4 M0.61%0.10%−2.4%May 31, 2026
🇺🇸 Fidelity Advisor Biotechnology FundFidelity Management & Research Company LLC120,995$3 M0.61%0.15%no changeJul 31, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC112,159$3 M0.56%<0.01%+3.1%Jul 31, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors78,065$3 M0.39%0.02%+2.0%Jun 30, 2026
🇺🇸 iShares Biotechnology ETFBlackRock Fund Advisors66,553$2 M0.33%0.03%−12%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.56,310$2 M0.28%0.01%+3.4%May 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC50,753$2 M0.25%<0.01%−2.6%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors34,417$1 M0.17%0.08%+24%Jun 30, 2026
🇺🇸 T. Rowe Price Health Sciences Fund, Inc.T. Rowe Price Associates, Inc.30,632$1 M0.15%<0.01%−75%Jun 30, 2026
🇺🇸 Small Cap Value FundNorthern Trust Investments, Inc.28,408$1 M0.14%0.14%newJun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.25,625$1 M0.13%<0.01%+5.5%Jul 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors19,539$1 M0.10%<0.01%+35%Jun 30, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC19,034$1 M0.10%0.01%no changeJun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC19,826$1 M0.10%<0.01%no changeMay 31, 2026
🇺🇸 ALPS Medical Breakthroughs ETFALPS Advisors, Inc.19,353$1 M0.10%0.37%+16%May 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust16,713$1 M0.08%0.02%+47%May 31, 2026
🇺🇸 JPMorgan U.S. Small Company FundJ.P. Morgan Investment Management Inc.13,971$0 M0.07%0.04%−6.7%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC14,801$0 M0.07%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC11,802$0 M0.06%0.02%+4.6%Jun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC12,644$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC13,514$0 M0.07%<0.01%+12%Jul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC10,609$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.10,971$0 M0.05%0.03%newJul 31, 2026
🇺🇸 JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc.8,806$0 M0.04%0.02%−5.8%Jun 30, 2026
🇺🇸 Columbia Variable Portfolio - Small Company Growth FundColumbia Management Investment Advisers, LLC8,302$0 M0.04%0.11%−8.7%Jun 30, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation7,800$0 M0.04%0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP7,996$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.6,494$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.6,993$0 M0.04%0.02%+5.4%May 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.5,979$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.5,470$0 M0.03%0.01%no changeJun 30, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors5,318$0 M0.03%<0.01%−0.8%Jun 30, 2026
🇺🇸 Goldman Sachs Small Cap Value Insights FundGoldman Sachs Asset Management, L.P.5,529$0 M0.03%0.01%newJul 31, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC5,330$0 M0.03%<0.01%no changeJul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC4,323$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC4,059$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company4,416$0 M0.02%0.01%no changeMay 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC4,882$0 M0.02%<0.01%+2.1%Jul 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.3,900$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.4,711$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Acuitas US Microcap FundAcuitas Investments, LLC3,507$0 M0.02%0.10%—Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC3,381$0 M0.02%0.01%−20%Jun 30, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC3,967$0 M0.02%0.01%newJul 31, 2026
🇺🇸 LVIP JPMorgan Small Cap Core FundLincoln Financial Investments Corporation3,118$0 M0.02%0.04%−5.3%Jun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC3,060$0 M0.02%<0.01%+78%Jun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC3,060$0 M0.02%<0.01%+78%Jun 30, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC3,665$0 M0.02%<0.01%+3.5%Jul 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC2,888$0 M0.01%0.01%no changeJun 30, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP2,930$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC2,288$0 M0.01%0.04%+17%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Value PortfolioBrighthouse Investment Advisers, LLC2,166$0 M0.01%0.02%−14%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC2,161$0 M0.01%0.01%+7.2%Jun 30, 2026
🇺🇸 T. Rowe Price Health Sciences PortfolioT. Rowe Price Associates, Inc.2,081$0 M0.01%<0.01%−73%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS2,061$0 M0.01%0.01%no changeJun 30, 2026
🇺🇸 Vy Jpmorgan Small Cap Core Equity PortfolioVoya Investments, LLC2,052$0 M0.01%0.02%−5.0%Jun 30, 2026
🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.1,842$0 M<0.01%0.03%newJun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC1,702$0 M<0.01%<0.01%+18%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.1,809$0 M<0.01%<0.01%+2.7%May 31, 2026
🇺🇸 Small Cap Value FundThe Variable Annuity Life Insurance Company1,794$0 M<0.01%0.02%newMay 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.1,536$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.1,473$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC1,775$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC1,430$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC1,426$0 M<0.01%0.01%+20%Jun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC1,392$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS1,289$0 M<0.01%0.02%newJun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.1,276$0 M<0.01%<0.01%+14078%Jun 30, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC1,551$0 M<0.01%0.01%+5.4%Jul 31, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP1,551$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP1,512$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION1,300$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management1,122$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP1,127$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.1,002$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.1,090$0 M<0.01%<0.01%+6.5%Jul 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC1,040$0 M<0.01%<0.01%−18%Jul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC832$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP975$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS964$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Health Sciences TrustJohn Hancock Variable Trust Advisers LLC756$0 M<0.01%0.01%−72%Jun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC735$0 M<0.01%0.01%+11%Jun 30, 2026
🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC720$0 M<0.01%0.02%no changeJun 30, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC707$0 M<0.01%<0.01%+15%Jun 30, 2026
🇺🇸 SA Multi-Managed Small Cap PortfolioSunAmerica Asset Management, LLC659$0 M<0.01%0.02%−9.0%Jun 30, 2026
🇺🇸 EQ/T.Rowe Price Health Sciences PortfolioEquitable Investment Management Group, LLC536$0 M<0.01%0.01%−72%Jun 30, 2026
🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC641$0 M<0.01%<0.01%+85%Jul 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC517$0 M<0.01%<0.01%+8.6%May 31, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC465$0 M<0.01%<0.01%−39%Jun 30, 2026
🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS523$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC420$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC393$0 M<0.01%<0.01%no changeJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Tectonic Therapeutic, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$182 K
2 purchases, 2 insiders
Sold, 12 months
$651 K
11 sales, 2 insiders
Net, 12 months
-$469 K
open market only
Insiders on file
30
since
$40.2 M-$8.6 M$0May 2024: bought $0 (3 trades), sold $0 (0 trades)May 24Sep 2024: bought $1.4 M (4 trades), sold $0 (0 trades)Oct 2024: bought $10.1 M (1 trades), sold $0 (0 trades)OctFeb 2025: bought $40.2 M (3 trades), sold $0 (0 trades)Apr 2025: bought $10.8 M (10 trades), sold $8.6 M (1 trades)AprFeb 2026: bought $182 K (2 trades), sold $0 (0 trades)Mar 2026: bought $0 (0 trades), sold $567 K (5 trades)MarApr 2026: bought $0 (0 trades), sold $31 K (1 trades)May 2026: bought $0 (0 trades), sold $32 K (1 trades)MayJun 2026: bought $0 (0 trades), sold $6 K (1 trades)Aug 2026: bought $0 (0 trades), sold $3 K (2 trades)AugSep 2026: bought $0 (0 trades), sold $12 K (1 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Tectonic Therapeutic, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Alise ReicinChief Executive Officer, DirectorOption exercise+10,000$2.380$24 K319,078Form 4
filed Peter McNamaraChief Scientific OfficerSell10b5-1 plan-536$23.04$12 K54,305Form 4
filed Alise ReicinChief Executive Officer, DirectorShares withheld for tax-1,545$23.67$37 K309,078Form 4
filed Daniel LochnerChief Financial OfficerShares withheld for tax-520$23.67$12 K58,024Form 4
filed Marc SchwabishChief Business OfficerShares withheld for tax-411$23.67$10 K44,903Form 4
filed Peter McNamaraChief Scientific OfficerShares withheld for tax10b5-1 plan-444$23.67$11 K54,841Form 4
filed Marcella K. RuddyChief Medical OfficerShares withheld for tax-525$23.67$12 K67,157Form 4
filed Peter McNamaraChief Scientific OfficerOption exercise10b5-1 plan+43$14.71$63355,328Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Tectonic Therapeutic, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
2.4 M
12.7% of shares · 13.66 days to cover
Dividend per share, Q1 2025
$0.000
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-1.89 reverse split ; 4.312-for-1 split

Tectonic Therapeutic, Inc. dividends per share by quarter
Dividend, quarterPer share
Q1 2025$0.000

Trading halts

  • 2025-10-29 20:00 UTC, code T3, resumed 20:30 UTC
  • 2025-01-28 18:57 UTC, code LUDP, resumed 19:02 UTC
  • 2025-01-28 18:43 UTC, code LUDP, resumed 18:48 UTC
  • 2025-01-28 18:25 UTC, code LUDP, resumed 18:35 UTC
  • 2025-01-28 18:12 UTC, code LUDP, resumed 18:22 UTC

Fails to deliver

  • : 1,049 shares at $20.34
  • : 4,969 shares at $20.07
  • : 1 shares at $24.12
  • : 306 shares at $30.48
  • : 19,728 shares at $37.63

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Tectonic Therapeutic, Inc. scorecard#

Passes 2 of the 9 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 2
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-4.05 vs -6.83Diluted EPS -4.05 in fiscal 2025 against -6.83 the year before (report's currency).
    • ✓Net income higher than five years earlier-$74 M-$74 M in fiscal 2025 against -$120 M in 2020.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 3
    • ✗Profitable in the newest year-$74 MNet income -$74 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • –Operating margin above its peers' medianNo operating margin on file.
    • ✗Return on equity above 15%-37.8%-37.8% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 2
    • ✓Short-term assets cover short-term liabilities26.6×Current ratio 26.61 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 2
    • ✗Pays a dividendNoNo dividends in fiscal 2025.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year115.8%Diluted shares up 115.8% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Tectonic Therapeutic, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Tectonic Therapeutic, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017
Income statement
Research and development634137r728387553515
General and administrative21177.7r33363321113.2
Operating expenses845845r105119120764618
Total costs and expenses3.73.63.6r3.0—————
Operating income−84−58−45r−105−119−120−76−46−18
Interest and finance income114.30.6——0.72.91.70.1
Interest expense and finance costs0.10.10.2r1.80.2————
Other non-operating income (expense)110.01.8r−0.5−0.30.52.8−0.1−0.3
Income before tax−73−58———————
Income tax1.200r0—————
Net income including minority interests−74−58−43r−106−119−120−73−46−19
Net income attributable to shareholders−74−58−43r−106−119−120−73−46−19
Earnings per share, basic-4.05-6.83-33.76r-2.42-2.78-3.31-2.66-3.62-8.38
Earnings per share, diluted-4.05-6.83-33.76r-2.42-2.78-3.31-2.66-3.62-8.38
Shares, weighted average (basic)188.51.3r44r0.0————
Shares, weighted average (diluted)188.51.3r44r0.0r3627r132.2
Dividends per share0.000.00———————
Balance sheet
Cash and cash equivalents25414129r931902601871266.0
Other current assets3.05.60.61.01.70.3r0.3r0.80.1
Current assets25714731r1001992671961306.3
Property, plant and equipment1.22.23.1r2.94.13.13.72.60.3
Right-of-use (leased) assets0.92.22.7r1.10————
Total assets26115339r1042042712011337.0
Accounts payable1.11.00.4r0.43.52.73.92.80.5
Current liabilities9.71241r13191714112.6
Lease liabilities (non-current)00.11.6r0.20————
Total liabilities9.71243r29341715113.7
Retained earnings−223−149−91r−489−384−264−145−72−23
Shareholders' equity251141−85r−46r169254186122−23
Total liabilities and equity26115339r1042042712011337.0
Shares outstanding19151.4r4444r44r32r242.3
Cash-flow statement
Depreciation and amortization1.41.61.5r1.41.41.20.90.40.0
Share-based compensation103.51.1r1219166.82.20.2
Cash from operating activities−60−59−41r−97−98−99−68−38−16
Capital expenditure−0.2−0.2−0.3r−0.3−2.5−1.2−1.6−1.8−0.4
Cash from investing activities−0.1−0.2−0.3r−0.3−2.5−1.2−1.6−1.8−0.4
Debt issued———015————
Shares issued——0.10.2——129104—
Cash from financing activities17317234r0.33017313016017
Exchange-rate effect on cash−0.1−0.00.0——————
Change in cash113112−7.2r−97−7073611210.6
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Where Tectonic Therapeutic, Inc. operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 3 subsidiaries on file.

Tectonic Therapeutic, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office2 subsidiaries—
🇦🇺 Australia1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Tectonic Therapeutic, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$7.4 M
Alise Reicin
Other top executives, average
$3.1 M
the CEO earned 2.4× this
$100 invested is now
$244
Tectonic Therapeutic, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Alise Reicin$7.4 M−$4.4 M$3.1 M$244
2024Alise Reicin, Erik Ostrowski$5.9 M$16.2 M$2.1 M$540
2023Erik Ostrowski$1.6 M$1.9 M$1.1 M$191

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Tectonic Therapeutic, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling

Auditor changed 1 · Change in control 1 · Acquisition or sale completed 2 · Directors and officers 4 · Material agreement 2 · Unregistered share sale 2 · Shareholder rights changed 1 · Bylaws or fiscal year changed 1 · Shareholder vote 2 · Results announced 10

Tectonic Therapeutic, Inc.: events reported to the SEC
FiledWhat happenedFiling
Acquisition or sale completed8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Material agreementUnregistered share sale8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Auditor changedChange in controlAcquisition or sale completedDirectors and officersMaterial agreementUnregistered share saleShareholder rights changedBylaws or fiscal year changedResults announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 5, 2026

Acquisitions and funding#

2 private funding rounds before listing

Private share sales · funding history

Private share sales of Tectonic Therapeutic, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2025$185 MPrivate placement after listing$50 to $250 million29equitySEC
Jan 2018$61 MNo. 2$50 to $250 million15equitySEC
Jul 2016$8 MNo. 1$2 to $10 million3equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at Tectonic Therapeutic, Inc.#

1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $135 K a year.

Certified, FY2026
1
#1,892 among companies on value.today
Worker positions
1
Median wage offered
$135 K
a year, full-time
Applications filed
1
Tectonic Therapeutic, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Scientist IBiochemists and Biophysicists1$135 K

Where: Watertown, MA 1

Tectonic Therapeutic, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202611$135 K1
FY202511$124 K1
FY202411$87 K1
FY202311$100 K1
FY202211$65 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Tectonic Therapeutic, Inc.

Layoffs at Tectonic Therapeutic, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
600 K
2022–2024
Latest
600,000 people
2024-01-30
Tectonic Therapeutic, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2024600 K···········600 K
2023············—
2022············—
Tectonic Therapeutic, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
600,000 peopleRestructuring planSEC 8-K“Following completion of the ongoing dose escalation safety and PK/PD studies in healthy volunteers, development of TX45 is planned to focus on an area of very high unmet need, Grou…”Filing
50% of workforceRestructuring planSEC 8-K“The Board also approved a reduction in the Company’s workforce by approximately 50% across different areas and functions in the Company (the “ Workforce Reduction ”).”Filing
Not statedRestructuring planSEC 8-KCompany-wide planFiling
Not statedRestructuring planSEC 8-KCompany-wide planFiling
23% of workforceRestructuring planSEC 8-K“As part of this plan, the Committee approved a reduction in the Company’s workforce by approximately 23% across different areas and functions in the Company (the “Workforce Reducti…”Filing

Source: State WARN notices and SEC 8-K item 2.05

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Tectonic Therapeutic, Inc.🇺🇸$66 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 16, 2026

Figures from SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Tectonic Therapeutic, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Tectonic Therapeutic, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Tectonic Therapeutic, Inc.? Suggest a correction